Valion Bio
VBIOInstitutional ownership · Q2 2026
Institutional holders
12
+4 (+50.0%) vs Q1 2026
Reported value
$205.6K
-11.9% vs Q1 2026
Shares held
398.1K
+133.9K shares
Quarter
Q2 2026
Period ended Jun 30, 2026
12 institutional managers reported holding 398,070 shares worth $205,603 on Form 13F for Q2 2026, against 8 in Q1 2026. Share positions on CUSIP 888705308 only; option legs and principal-amount lines are not counted.
Top 12 institutional holders · Q2 2026
| # | Manager | Shares | Value | % of portfolio | Change | Position page |
|---|---|---|---|---|---|---|
| 1 | Murchinson Ltd | 115,000 | $59.8K | < 0.01% | New | Position |
| 2 | CITADEL ADVISORS LLC | 74,145 | $38.5K | < 0.01% | New | Position |
| 3 | Sanctuary Advisors LLC | 61,205 | $31.8K | < 0.01% | — | Position |
| 4 | Marex Group plc | 54,287 | $28.2K | < 0.01% | -5.0K | Position |
| 5 | Virtu Financial LLC | 39,225 | $20.0K | < 0.01% | New | Position |
| 6 | GEODE CAPITAL MANAGEMENT LLC | 19,374 | $10.1K | < 0.01% | -68.4K | Position |
| 7 | UBS Group AG | 11,094 | $5.8K | < 0.01% | +8.7K | Position |
| 8 | TWO SIGMA SECURITIES LLC | 10,162 | $5.3K | < 0.01% | New | Position |
| 9 | HRT FINANCIAL LP | 11,462 | $5.0K | < 0.01% | -31.0K | Position |
| 10 | Tower Research Capital LLC TRC | 2,095 | $1.1K | < 0.01% | +1.5K | Position |
| 11 | SBI Securities Co Ltd | 16 | $8 | < 0.01% | — | Position |
| 12 | TD Waterhouse Canada Inc | 5 | $2 | < 0.01% | New | Position |
Values as reported on each manager's Q2 2026 Form 13F. Change is in shares against the manager's prior-quarter filing.
Across other SEC filings
Fund holders · N-PORT
1 fund| Fund | Value | % of fund | As of |
|---|---|---|---|
| Fidelity Extended Market Index Fund | $38.6K | < 0.01% | May 2026 |
1 fund reported holding $38,562 in total on their latest public Form N-PORT reports, the most recent dated May 2026.
Insiders · Form 4
Net insider transactions, 12 months
+$28.4K
2 filings with purchases ($28.4K),
0 filings with sales ($0)
Latest filings
- Dean Zikria 2026-09-24 Award
- Lisa G Wolf 2026-09-24 Exercise
- Lisa G Wolf 2026-06-18 Exercise
- Michael K Handley 2026-05-20 Exercise
- Melinda Lackey 2026-05-04 Award
5%+ holders · 13D/G
2 filers| Filer | % of class | Filed |
|---|---|---|
| 3i LP 13D | 9.9% | 2026-08-20 |
| Murchinson Ltd 13G | 10.0% | 2026-07-17 |
Latest Schedule 13D or 13G from each filer naming this CUSIP; stakes a filer has reported closed are left out.
Annual & quarterly reports
-
10-K · FY2025 Filed 2026-03-30Business · Risk Factors · Management's Discussion and Analysis
Federal lobbying
Spend, trailing 12 months
$20.0K
Through Q3 2026, from quarterly LD-2 reports
Valion Bio lobbying profile
Ownership explorer
Loading ownership explorer…
Security Details
| CUSIP | 888705308 |
|---|---|
| Symbol | VBIO |
| Type | Common stock |
| Class | COM as filed on 13F |
| Company | Valion Bio |
Other securities from this issuer
| Name | Symbol | CUSIP | Type |
|---|---|---|---|
| TIVIC HEALTH SYSTEMS INC | TIVC | 888705209 | Common stock |
Identifier History
| Type | Value | From | To |
|---|---|---|---|
| CUSIP | 888705308 | 2026-03-31 | Current |
Listing History
| Symbol | Exchange | From | To |
|---|---|---|---|
| VBIO | US | 2026-06-01 | Current |